Pcovery (private company)

Pcovery is a focused drug discovery company within the anti-fungal area. We combine our expertise within protein structure, medicinal chemistry, drug discovery and -development, and pathogenic fungal infections to create a novel class of anti-fungals to treat serious invasive fungal infections.

Pcovery's research platform combines a number of powerful technologies to identify, evaluate and optimize novel antifungal compounds. We carry out high throughput in vitro and in vivo fungicidal activity screens, specificity, synergy and resistance screenings, as well as structural characterization of drug-target interactions by X-ray crystallography.

Our research team and advisors include specialists in anti-fungal drug development, chemistry, biochemistry, structural biology and membrane transport, providing us with a unique set of expertise to achieve our ambitious goal of developing a powerful novel type of anti-fungal drug.

Pcovery was founded in 2009 aided by a pre-Seed grant from Novo Seeds. The first Seed round was made in 2010 by Østjysk Innovation and Novo Seeds. In 2013 a second Seed round was made by the existing investors. Also in 2013 Pcovery received a Seeding Drug Discovery Award of up to £3.7 m from the Wellcome Trust.